US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Industrials Momentum ETF

201.63

+10.215.33%

Post-market: 201.630.00000.00%17:34 EST

Volume:33.21K

Turnover:6.66M

Market Cap:342.77M

PE:1.86K

High:202.15

Open:195.04

Low:195.04

Close:191.42

52wk High:202.15

52wk Low:118.25

Shares:1.70M

Float Shares:1.70M

Volume Ratio:1.60

T/O Rate:1.95%

Dividend:0.29

Dividend Rate:0.14%

EPS(TTM):0.1085

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Is Citi’s Drilling Momentum Call Reframing Perenti’s (ASX:PRN) Core Investment Story?

Simply Wall St.

Perenti's (ASX:PRN) five-year total shareholder returns outpace the underlying earnings growth

Simply Wall St.

Kepler Capital Reaffirms Their Buy Rating on Princes Group Plc (PRN)

Perenti (ASX:PRN) Ticks All The Boxes When It Comes To Earnings Growth

Simply Wall St.

It's A Story Of Risk Vs Reward With Perenti Limited (ASX:PRN)

Simply Wall St.

Lake Street Reaffirms Their Buy Rating on Profound Medical (PRN)

These 4 Measures Indicate That Perenti (ASX:PRN) Is Using Debt Reasonably Well

Simply Wall St.

Lake Street Remains a Buy on Profound Medical (PRN)

Perenti's (ASX:PRN) Upcoming Dividend Will Be Larger Than Last Year's

Simply Wall St.

How Perenti’s Dividend Hike Could Influence Capital Allocation Strategy for Investors (ASX:PRN)

Simply Wall St.

Lake Street Keeps Their Buy Rating on Profound Medical (PRN)

Perenti Limited's (ASX:PRN) Intrinsic Value Is Potentially 99% Above Its Share Price

Simply Wall St.

Raymond James Sticks to Their Buy Rating for Profound Medical (PRN)

Press Release: Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital

Perenti's (ASX:PRN) three-year earnings growth trails the strong shareholder returns

Simply Wall St.

MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PRN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRN\",,,,,undefined,":{"symbol":"PRN","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Industrials Momentum ETF","latestPrice":201.63,"timestamp":1770411600000,"preClose":191.42,"halted":0,"volume":33208,"hourTrading":{"tag":"盘后","latestPrice":201.63,"preClose":201.63,"latestTime":"17:34 EST","volume":52,"amount":10509.56,"timestamp":1770417240516,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.05333820917354513,"floatShares":1700000,"shares":1700000,"eps":0.10851,"marketStatus":"Market Closed","change":10.21,"latestTime":"02-06 16:00:00 EST","open":195.04,"high":202.1499,"low":195.04,"amount":6658900.3717600005,"amplitude":0.037143,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0.10851,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":191.42,"sharesOutstanding":1700000,"nav":191.42198,"aum":343116983.62,"dividendRate":0.001426,"bidAskSpread":0.001736,"preHourTrading":{"tag":"盘前","latestPrice":195.01,"preClose":191.42,"latestTime":"09:29 EST","volume":4,"amount":776.44996,"timestamp":1770388199999,"change":3.59,"changeRate":0.018755,"amplitude":0.018755},"postHourTrading":{"tag":"盘后","latestPrice":201.63,"preClose":201.63,"latestTime":"17:34 EST","volume":52,"amount":10509.56,"timestamp":1770417240516,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.6005552449917038,"impliedVol":0.2215,"impliedVolPercentile":0.9283},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRN\",,,,,undefined,":{"symbol":"PRN","floatShares":1700000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.6005552449917038,"shares":1700000,"dividePrice":0.2876,"high":202.1499,"amplitude":0.037143,"preClose":191.42,"low":195.04,"week52Low":118.25,"pbRate":"--","week52High":202.1499,"institutionHeld":0,"latestPrice":201.63,"eps":0.10851,"divideRate":0.001426,"volume":33208,"delay":0,"ttmEps":0.10851,"open":195.04,"prevYearClose":174.576,"prevWeekClose":192.7452,"prevMonthClose":192.7452,"prevQuarterClose":174.576,"fiveDayClose":192.7452,"twentyDayClose":181.7004,"sixtyDayClose":178.851},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRN\",params:#limit:5,,,undefined,":[{"date":"2025-09-22","symbol":"PRN","amount":0.21062,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Dorsey Wright Industrials Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"PRN","amount":0.07178,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Dorsey Wright Industrials Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-24","symbol":"PRN","amount":0.00604,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"Invesco Dorsey Wright Industrials Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PRN","amount":0.24968,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"Invesco Dorsey Wright Industrials Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-27"},{"date":"2024-09-23","symbol":"PRN","amount":0.24317,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-23","defaultRemindTime":1727098200000,"name":"Invesco Dorsey Wright Industrials Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-27","payableDate":"2024-09-23","currency":"USD","dateTimestamp":1727064000000,"payDate":"2024-09-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRN\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-30","value":0.09452,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.04241,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.14938,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-30","value":0.11112,"currency":"USD"},{"executeDate":"2017-09-18","recordDate":"2017-09-19","paymentDate":"2017-09-29","value":0.25297,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606735767","title":"Is Citi’s Drilling Momentum Call Reframing Perenti’s (ASX:PRN) Core Investment Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2606735767","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606735767?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:24","pubTimestamp":1769523859,"startTime":"0","endTime":"0","summary":"Citi recently highlighted improved drilling momentum at Perenti, pointing to operational progress in the company’s core drilling services segment.\nThis renewed focus on drilling activity underscores how operational trends within Perenti’s core business can meaningfully influence investor perceptions of the group.\nWe’ll now examine how Citi’s emphasis on stronger drilling momentum could shape Perenti’s broader investment narrative for investors.\nExplore 23 top quantum computing companies...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/is-citis-drilling-momentum-call-reframing-perentis-asxprn-co","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/is-citis-drilling-momentum-call-reframing-perentis-asxprn-co","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRN","BK7095","PRN.AU"],"gpt_icon":0},{"id":"2606425699","title":"Perenti's (ASX:PRN) five-year total shareholder returns outpace the underlying earnings growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2606425699","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606425699?lang=en_us&edition=fundamental","pubTime":"2026-01-25 06:02","pubTimestamp":1769292141,"startTime":"0","endTime":"0","summary":"The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perentis-asxprn-five-year-total-shareholder-returns-outpace","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perentis-asxprn-five-year-total-shareholder-returns-outpace","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRN","PRN.AU"],"gpt_icon":0},{"id":"2603685859","title":"Kepler Capital  Reaffirms Their Buy Rating on Princes Group Plc (PRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603685859","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603685859?lang=en_us&edition=fundamental","pubTime":"2026-01-16 15:25","pubTimestamp":1768548351,"startTime":"0","endTime":"0","summary":"Kepler Capital analyst Hakon Nelson maintained a Buy rating on Princes Group Plc on January 14 and set a price target of p600.00. The company’s sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/kepler-capital-reaffirms-their-buy-rating-on-princes-group-plc-prn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/kepler-capital-reaffirms-their-buy-rating-on-princes-group-plc-prn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRN"],"gpt_icon":0},{"id":"2593452124","title":"Perenti (ASX:PRN) Ticks All The Boxes When It Comes To Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2593452124","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593452124?lang=en_us&edition=fundamental","pubTime":"2025-12-23 04:00","pubTimestamp":1766433609,"startTime":"0","endTime":"0","summary":"It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perenti-asxprn-ticks-all-the-boxes-when-it-comes-to-earnings","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perenti-asxprn-ticks-all-the-boxes-when-it-comes-to-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRN","PRN.AU"],"gpt_icon":0},{"id":"2588174337","title":"It's A Story Of Risk Vs Reward With Perenti Limited (ASX:PRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2588174337","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588174337?lang=en_us&edition=fundamental","pubTime":"2025-12-01 06:02","pubTimestamp":1764540137,"startTime":"0","endTime":"0","summary":"With a median price-to-earnings (or \"P/E\") ratio of close to 22x in Australia, you could be forgiven for feeling...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/its-a-story-of-risk-vs-reward-with-perenti-limited-asxprn-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/its-a-story-of-risk-vs-reward-with-perenti-limited-asxprn-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRN.AU","PRN","BK7095"],"gpt_icon":0},{"id":"2584731942","title":"Lake Street Reaffirms Their Buy Rating on Profound Medical (PRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584731942","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584731942?lang=en_us&edition=fundamental","pubTime":"2025-11-19 21:56","pubTimestamp":1763560561,"startTime":"0","endTime":"0","summary":"Lake Street analyst Ben Haynor maintained a Buy rating on Profound Medical today and set a price target of $11.00. According to TipRanks, Haynor is...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-reaffirms-their-buy-rating-on-profound-medical-prn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-reaffirms-their-buy-rating-on-profound-medical-prn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRN"],"gpt_icon":0},{"id":"2584369757","title":"These 4 Measures Indicate That Perenti (ASX:PRN) Is Using Debt Reasonably Well","url":"https://stock-news.laohu8.com/highlight/detail?id=2584369757","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584369757?lang=en_us&edition=fundamental","pubTime":"2025-11-17 06:01","pubTimestamp":1763330492,"startTime":"0","endTime":"0","summary":"David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/these-4-measures-indicate-that-perenti-asxprn-is-using-debt","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/these-4-measures-indicate-that-perenti-asxprn-is-using-debt","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRN","PRN.AU","EBIT","BK7095"],"gpt_icon":0},{"id":"2583072405","title":"Lake Street Remains a Buy on Profound Medical (PRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583072405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583072405?lang=en_us&edition=fundamental","pubTime":"2025-11-14 23:16","pubTimestamp":1763133362,"startTime":"0","endTime":"0","summary":"In a report released today, Ben Haynor from Lake Street maintained a Buy rating on Profound Medical, with a price target of $11.00. According to Ti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-remains-a-buy-on-profound-medical-prn-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-remains-a-buy-on-profound-medical-prn-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRN"],"gpt_icon":0},{"id":"2575220708","title":"Perenti's (ASX:PRN) Upcoming Dividend Will Be Larger Than Last Year's","url":"https://stock-news.laohu8.com/highlight/detail?id=2575220708","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575220708?lang=en_us&edition=fundamental","pubTime":"2025-10-15 04:30","pubTimestamp":1760473828,"startTime":"0","endTime":"0","summary":"The board of Perenti Limited ( ASX:PRN ) has announced that the dividend on 30th of October will be increased to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perentis-asxprn-upcoming-dividend-will-be-larger-than-last-y","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perentis-asxprn-upcoming-dividend-will-be-larger-than-last-y","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRN","PRN.AU","BK7095"],"gpt_icon":0},{"id":"2574946707","title":"How Perenti’s Dividend Hike Could Influence Capital Allocation Strategy for Investors (ASX:PRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2574946707","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574946707?lang=en_us&edition=fundamental","pubTime":"2025-10-12 08:26","pubTimestamp":1760228760,"startTime":"0","endTime":"0","summary":"Perenti Limited recently announced a periodic dividend increase to A$0.0425 on October 30th, marking a 6.3% rise compared to last year.\nThis move highlights the company's strong earnings growth and careful balance between reinvestment and delivering higher dividends to shareholders.\nLet's explore how the recent dividend increase underscores Perenti's robust financial foundation and shapes its investment outlook.\nThese 10 companies survived and thrived after COVID and have the right...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/how-perentis-dividend-hike-could-influence-capital-allocatio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/how-perentis-dividend-hike-could-influence-capital-allocatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4211","PRN.AU","PRN","ISBC","BK7095"],"gpt_icon":0},{"id":"2573968458","title":"Lake Street Keeps Their Buy Rating on Profound Medical (PRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2573968458","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573968458?lang=en_us&edition=fundamental","pubTime":"2025-10-07 21:16","pubTimestamp":1759842962,"startTime":"0","endTime":"0","summary":"Lake Street analyst Ben Haynor maintained a Buy rating on Profound Medical today and set a price target of $11.00. The company’s shares closed yest...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-profound-medical-prn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lake-street-keeps-their-buy-rating-on-profound-medical-prn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRN"],"gpt_icon":0},{"id":"2573939668","title":"Perenti Limited's (ASX:PRN) Intrinsic Value Is Potentially 99% Above Its Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2573939668","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573939668?lang=en_us&edition=fundamental","pubTime":"2025-10-07 04:42","pubTimestamp":1759783330,"startTime":"0","endTime":"0","summary":"Key Insights Perenti's estimated fair value is AU$5.74 based on 2 Stage Free Cash Flow to Equity Perenti is estimated...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perenti-limiteds-asxprn-intrinsic-value-is-potentially-99-ab","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perenti-limiteds-asxprn-intrinsic-value-is-potentially-99-ab","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4100","BK7095","BK4211","TV","PRN.AU","FCF","PRN","DCF"],"gpt_icon":0},{"id":"2570011456","title":"Raymond James Sticks to Their Buy Rating for Profound Medical (PRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2570011456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570011456?lang=en_us&edition=fundamental","pubTime":"2025-09-25 23:15","pubTimestamp":1758813320,"startTime":"0","endTime":"0","summary":"Raymond James analyst Michael W. Freeman reiterated a Buy rating on Profound Medical today and set a price target of $11.00. The company’s shares o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/raymond-james-sticks-to-their-buy-rating-for-profound-medical-prn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/raymond-james-sticks-to-their-buy-rating-for-profound-medical-prn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRN","RJF"],"gpt_icon":0},{"id":"2570094808","title":"Press Release: Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital","url":"https://stock-news.laohu8.com/highlight/detail?id=2570094808","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570094808?lang=en_us&edition=fundamental","pubTime":"2025-09-25 19:41","pubTimestamp":1758800460,"startTime":"0","endTime":"0","summary":"- Transaction designed to accelerate development of RT234 , an investigational first-in-class, as-needed  treatment for PAH and PH-ILD -. PALO ALTO, Calif., Sept. 25, 2025 /PRNewswire/ -- Respira Therapeutics, Inc. , a Samsara BioCapital portfolio company, today announced that it has entered into an agreement with Gossamer Bio, Inc.   granting Gossamer an option to acquire the Company.Respira is developing RT234  as the first as-needed  therapy for use in pulmonary hypertension . RT234 is designed to rapidly improve PH patient function and symptoms, including for pulmonary arterial hypertension  and pulmonary hypertension associated with interstitial lung disease . There are no approved PRN therapies for PAH or PH-ILD, and despite existing treatment options, the majority of PH patients continue to struggle with debilitating symptoms that disrupt daily life and limit their independence.Respira Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing RT234  ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","LU0211331839.USD","PH","LU0320765489.SGD","BK4139","BK4604","03160","BK4161","BK4539","BK4555","LU1988902786.USD","LU0070302665.USD","PRN","LU0256863902.USD","LENZ","TM","BK4099","BK4007","BK4580","BK4585","LU1064131342.USD","LU0256863811.USD","BK4505","LU1989772923.USD","LU0208291251.USD","LU2264538146.SGD","BK4588","LU1989772840.SGD","LU0417517546.SGD"],"gpt_icon":0},{"id":"2569763064","title":"Perenti's (ASX:PRN) three-year earnings growth trails the strong shareholder returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2569763064","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569763064?lang=en_us&edition=fundamental","pubTime":"2025-09-23 04:39","pubTimestamp":1758573543,"startTime":"0","endTime":"0","summary":"The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perentis-asxprn-three-year-earnings-growth-trails-the-strong","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-prn/perenti-shares/news/perentis-asxprn-three-year-earnings-growth-trails-the-strong","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRN.AU","PRN"],"gpt_icon":0},{"id":"2569867037","title":"MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2569867037","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569867037?lang=en_us&edition=fundamental","pubTime":"2025-09-22 19:00","pubTimestamp":1758538800,"startTime":"0","endTime":"0","summary":"Statistically significant responder rate achieved at 12 weeks with zero contribution from rescue therapy (PRN) and further improvement sustained in open-label extension (OLE) Positive findings in bone","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/22/3153770/0/en/MBX-Biosciences-Announces-Once-Weekly-Canvuparatide-Achieved-Primary-Endpoint-in-Phase-2-Trial-with-63-Responder-Rate-at-12-Weeks-79-Responder-Rate-at-6-Months-in-Open-Label-Extens.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBH","PK","PTH","BK4092","HP","PRN","BK4181","BK4218","MBX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}